Remove Packaging Remove Pharmaceutical Manufacturing Remove Process Improvement
article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

It attributed Indias cost advantage to high-production capacity plants, process improvements, economies of scale, and backward integration in manufacturing. IPA also addressed concerns regarding transparency in drug manufacturing locations.

article thumbnail

Best CDMO Practices for Startups: Navigating the Complex World of Contract Development and Manufacturing

Drug Patent Watch

Assessing Your Technical Needs Every drug is unique, and so are its manufacturing requirements. Take the time to clearly define your technical needs, from drug substance manufacturing to packaging requirements. Managing Quality and Compliance Quality and regulatory compliance are non-negotiable in pharmaceutical manufacturing.

article thumbnail

Corrective and Preventive Action (CAPA) Procedure for GMP

GMPSOP

Corrective and preventive actions are identified and implemented as the outcome of investigations such as deviations, product complaints, internal audit observations, risk assessments, stability failure, or other process or system-related non-conformances. The entire unused packaging lot which was quarantined was returned to the supplier.